Cargando…

Adoptive Transfer of EBV Specific CD8(+) T Cell Clones Can Transiently Control EBV Infection in Humanized Mice

Epstein Barr virus (EBV) infection expands CD8(+) T cells specific for lytic antigens to high frequencies during symptomatic primary infection, and maintains these at significant numbers during persistence. Despite this, the protective function of these lytic EBV antigen-specific cytotoxic CD8(+) T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antsiferova, Olga, Müller, Anne, Rämer, Patrick C., Chijioke, Obinna, Chatterjee, Bithi, Raykova, Ana, Planas, Raquel, Sospedra, Mireia, Shumilov, Anatoliy, Tsai, Ming-Han, Delecluse, Henri-Jacques, Münz, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148450/ https://www.ncbi.nlm.nih.gov/pubmed/25165855 http://dx.doi.org/10.1371/journal.ppat.1004333

Ejemplares similares

Progress in EBV Vaccines
por: van Zyl, Dwain G., et al.
Publicado: (2019)

Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
por: van Zyl, Dwain G., et al.
Publicado: (2018)

EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018)

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
por: Caduff, Nicole, et al.
Publicado: (2021)

EBV renders B cells susceptible to HIV-1 in humanized mice
por: McHugh, Donal, et al.
Publicado: (2020)

EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription
por: Tsai, Kevin, et al.
Publicado: (2011)

Modification of EBV-Associated Pathologies and Immune Control by Coinfections
por: Münz, Christian
Publicado: (2021)

Analysis of the miRNA targetome in EBV-infected B cells
por: Skalsky, Rebecca L, et al.
Publicado: (2012)

EBV Latency Types Adopt Alternative Chromatin Conformations
por: Tempera, Italo, et al.
Publicado: (2011)

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
por: Caduff, Nicole, et al.
Publicado: (2020)

Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
por: Caduff, Nicole, et al.
Publicado: (2020)

Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice
por: Gregorovic, Goran, et al.
Publicado: (2015)

EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes
por: Bieling, Maren, et al.
Publicado: (2017)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies
por: Chatterjee, Koustav, et al.
Publicado: (2019)

DNA Damage Signaling Is Induced in the Absence of Epstein—Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA
por: Wang'ondu, Ruth, et al.
Publicado: (2015)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

EBV Chronic Infections
por: Eligio, Pizzigallo, et al.
Publicado: (2010)

EBV and human cancer
por: Ko, Young-Hyeh
Publicado: (2015)

Antiviral Drugs for EBV
por: Pagano, Joseph S., et al.
Publicado: (2018)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
por: Kanduc, Darja, et al.
Publicado: (2020)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
por: Alberti, Andrea, et al.
Publicado: (2023)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Reduced frequency of cytotoxic CD56(dim) CD16(+) NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
por: Pánisová, Elena, et al.
Publicado: (2021)

The Characteristics of Epstein‐Barr Virus (EBV)‐positive Diffuse Large B‐Cell Lymphoma: Comparison between EBV(+) and EBV(‐) Cases in Japanese Population
por: Kuze, Tetuo, et al.
Publicado: (2000)

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells
por: Espinoza, J. Luis, et al.
Publicado: (2012)

Age-related EBV positive clonal B-cell Lymphoid proliferation (EBV+-DLBCL)
por: Georgakopoulou, Eleni, et al.
Publicado: (2017)

Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV
por: Venturini, Cristina, et al.
Publicado: (2021)

Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
por: Schuhmachers, Patrick, et al.
Publicado: (2021)

Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
por: Bonifacius, Agnes, et al.
Publicado: (2023)

EBV covers its tracks
por: Bashyam, Hema
Publicado: (2007)

EBV and HIV-Related Lymphoma
por: Bibas, Michele, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_hfr864dhu439t4du3vv9si8str